Rapafusyn Pharmaceuticals Funding & Investors
Baltimore, MD
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle. The company develops novel pharmaceuticals to treat patients having diseases and fulfill other unmet medical needs.
rapafusyn.comTotal Amount Raised: $28,000,000
Rapafusyn Pharmaceuticals Funding Rounds
Series A
$28,000,000
Series A Investors
3E Bioventures CapitalProxima VenturesLapam Capital
Funding info provided by Diffbot.